Archive for October, 2008

News: IMPAX Sued Based on ANDA for Generic Flomax(R). Genetic …

Tuesday, October 28th, 2008

IMPAX Laboratories, Inc. today announced Boehringer Ingelheim
Pharmaceuticals Inc. (”Boehringer”) and Astellas Pharma Inc.
(”Astellas”) have filed suit for patent infringement in the United
States District Court for the Northern District of California based on
the Company’s submission of Abbreviated New Drug Application (”ANDA”)
for tamsulosin hydrochloride capsules (0.4 mg), generic of Flomax(R),
to the Food…

Modern Healthcare - Collateral damage; Providers face negative fallout from the war on drugmakers.(health care providers)(Statistical Data Included)

Friday, October 24th, 2008

The avalanche of civil whistleblower and class-action lawsuits, state and federal criminal investigations and antitrust inquiries involving the marketing and pricing practices of the prescription-drug industry is likely to ripple throughout the healthcare industry, leaving few provider sectors untouched, government officials and healthcare lawyers say.

Related Results

Treating BPH with Alpha Blockers

Saturday, October 18th, 2008

If you are a man over 55 you have a 25% chance of suffering the effects of BPH. This acronym stands for benign prostatic hyperplasia (or benign prostatic hypertrophy). The male prostate gland is a male organ located below the bladder and surrounding the urethra. One purpose it has is to control the flow or urine. A man with BPH is likely experiencing urinary pro…

Chemistry and Industry - Drug collusion charges.(Brief Article)

Monday, October 13th, 2008

The US Federal Trade Commission has filed charges against drug firms Aventis and Andrx over the suppression of generic drug competition. The charges allege that Hoechst Marion Roussel, now part of Aventis, paid Andrx several million dollars to delay the launch of generic version of its hypertension drug Cardizem. Both companies deny that they acted …

Related Results

Saturday Evening Post - Bathroom trips disrupt sleep

Thursday, October 9th, 2008

Dear Dr. SerVaas,
I’m writing to you in regard to my getting up to the bathroom five or six times per night. I’ve been on Flomax and Avodart for about five years, to no avail. What’s the next move? I need sleep.
Alvin Graf
Jamestown, North Dakota

Medical Marketing and Media - Wall street choice: Abbott expected to outperform

Monday, October 6th, 2008

Herbert Saftlas Equity analyst Standard & Poor’s
Stock: Abbott Laboratories Rating: 4 stars (accumulate) Quality Rating: A (appraisal of growth and stability of earnings)
This diversified healthcare company operates in the areas of pharmaceuticals, diagnostics, hospital products and nutritionals.
In August, Abbott announced plans to spin of…

European Rubber Journal - Half of sales overseas.(News)(Skellmax Industries)(Brief Article)

Thursday, October 2nd, 2008

Skellmax Industries was formed in 2002 by combining dairy and industrial rubber part maker Skellerup Industries Ltd with vacuum pump maker Flomax International Ltd. The firm floated on the New Zealand Stock Exchange in June 2002.
In the year ended 30 June 2003, …